Mostrando 1 - 20 Resultados de 45 Para Buscar '"Sharp and Dohme"', tiempo de consulta: 0.99s Limitar resultados
  1. 1
    “…(Employee) Kara Bickham, MD, Merck Sharp and Dohme (Employee, Shareholder) Gretchen Tamms, B.S., Merck Sharp and Dohme (Employee, Shareholder) Richard McFetridge, B.S., Merck & Co., Inc (Employee) Robert Lupinacci, M.S, Merck & Co., Inc (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1174. Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Catch-up Vaccination Regimens of V114 in Healthy Infants, Children, and Adolescents (PNEU–PLAN)
  2. 2
    “…Cornely, Amplyx Pharmaceuticals, Basilea Pharmaceutica, F2G, Gilead Sciences, MSD Sharp and Dohme, Scynexis Inc.: Consultant, Consulting fee; Amplyx Pharmaceuticals, Basilea Pharmaceutica, F2G, Gilead Sciences, MSD Sharp and Dohme, Scynexis Inc.: Grant Investigator, Research grant; Basilea Pharmaceutica, Gilead Sciences, MSD Sharp and Dohme, Pfizer: Speaker’s Bureau, Speaker honorarium.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2046. FungiScope™: News on the Global Emerging Fungal Infection Registry
  3. 3
    “…Cornely, Amplyx Pharmaceuticals, Basilea Pharmaceutica, F2G, Gilead Sciences, MSD Sharp and Dohme, Scynexis Inc.: Consultant, Consulting fee Amplyx Pharmaceuticals, Basilea Pharmaceutica, F2G, Gilead Sciences, MSD Sharp and Dohme, Scynexis Inc.: Grant Investigator, Research grant Basilea Pharmaceutica, Gilead Sciences, MSD Sharp and Dohme, Pfizer: Speaker’s Bureau, Speaker honorarium…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    403. Prognostic Factors in 260 Adults With Invasive Scedosporiosis From Literature and FungiScope™
  4. 4
    “…Ramirez, Pfizer: Speaker’s Bureau, Speaker honorarium; GlaxoSmithKline: Consultant, Consulting fee; Merck Sharp and Dohme: Consultant, Consulting fee. J. Melo-Cristino, Pfizer: Grant Investigator and Speaker’s Bureau, Research grant and Speaker honorarium; Merck Sharp and Dohme.: Speaker’s Bureau, Speaker honorarium.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1443. Serotypes 8 and 3 Are the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2015–2017)
  5. 5
    “…Ramirez, Pfizer: Speaker’s Bureau, Speaker honorarium; GlaxoSmithKline: Consultant, Consulting fee; Merck Sharp and Dohme: Consultant, Consulting fee. J. Melo-Cristino, Pfizer: Grant Investigator and Speaker’s Bureau, Research grant and Speaker honorarium; Merck Sharp and Dohme.: Speaker’s Bureau, Speaker honorarium.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1452. Non-invasive Pneumococcal Pneumonia in Adults in Portugal: Continued Decline of PCV13 Serotypes (2015–2017)
  6. 6
    “…Every morning animals from the experimental group (15 rats) received rofecoxib (suspension in physiological saline)—non-steroidal anti-inflammatory drug (Vioxx©, Merck Sharp and Dohme, the USA), through an intragastric tube in the dose of 1.25 mg during 8 weeks. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies
  7. 7
    “…We investigated the relationship between the humoral and cellular immune response to a live-attenuated HZ vaccine (Zostavax(®), Merck Sharp and Dohme) and the frequencies of T and B cell subsets, especially aged cell subsets (CD28−T cells and age associated B cells, ABCs). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ageing of Immune System and Response to a Live-Attenuated Herpes Zoster Vaccine in Lung Transplant Candidates
  8. 8
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological‐based pharmacokinetic modeling
  9. 9
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Phase 1 Trial to Evaluate the Relationship Between Fluoride Intake and Urinary Fluoride Excretion in Healthy Participants
  10. 10
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical Formulation Bridging of Gefapixant, a P2X3‐Receptor Antagonist, for the Treatment of Chronic Cough
  11. 11
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical and healthcare burden of disease associated with cytomegalovirus in allogeneic hematopoietic stem cell transplantation – A retrospective single‐center study
  12. 12
    “…Analyses were restricted to fertility-related payments by two major manufacturers of fertility medicines in Australia: Merck Serono and Merck, Sharp and Dohme (MSD). PRIMARY AND SECONDARY OUTCOME MEASURES: Descriptive statistics on fertility-related payments and other transfers of value (counts, total and median costs in Australian dollars) for educational events and to healthcare professionals and patient groups. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study
  13. 13
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV
  14. 14
    “…DISCLOSURES: E. Ernst, Merck Sharp and Dohme: Consultant, Consulting fee.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of an Antimicroibal Stewardship Bundle of Rapid Identification of Methicillin Susceptibility and Active Intervention on Treatment of Staphylococcus aureus Bacteremia
  15. 15
    “…Falsey, MD, BioFire Diagnostics: Grant/Research Support|Janssen: Grant/Research Support|Merck, Sharp and Dohme: Grant/Research Support|Novavax: Advisor/Consultant|Pfizer: Grant/Research Support.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2208. Rates of Medically-Attended RSV among US Adults: A Systematic Review and Meta-Analysis
  16. 16
    “…Martin, MD, Merck Sharp and Dohme (Consultant)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1328. Risk Factors for Severe Influenza Outcomes Among Infants Born Between 2011 and 2019
  17. 17
    “…(Funded by Merck Sharp and Dohme; MOVe-OUT ClinicalTrials.gov number, NCT04575597.)…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
  18. 18
    por Mann, Inderjit, Okhuysen, Pablo C
    Publicado 2023
    “…Okhuysen, M.D., FACP, FIDSA, Astra Zeneca: Stocks/Bonds|Beam Therapeutics: Stocks/Bonds|Biontech: Stocks/Bonds|Deinove Pharmaceutucals: Grant/Research Support|Ferring: Advisor/Consultant|GSK PLC: Stocks/Bonds|Haleon: Stocks/Bonds|Johnson and Johnson: Stocks/Bonds|Melinta Pharmaceuticals: Grant/Research Support|Merk Sharp and Dohme: Grant/Research Support|Moderna: Stocks/Bonds|Napo Pharmaceuticals: Advisor/Consultant|Napo Pharmaceuticals: Grant/Research Support|Novavax: Stocks/Bonds|Pfizer: Stocks/Bonds|SNIPR Biome: Advisor/Consultant|Summit Pharmaceuticals: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    656. Cryptosporidiosis in Immunocompromised Patients with Cancer Receiving Chemotherapy, CAR-T Cell Therapy and Hematopoietic Stem Cell Transplantation: A Retrospective Analysis
  19. 19
    “…Hernández-Gómez, Merck Sharp and Dohme, Pfizer: Consultant, Consulting fee; C. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Plasmid Promiscuity Explains High Endemicity of KPC-2 Among Colombian Enterobacteriaceae
  20. 20
    “…Martin, MD, Merck Sharp and Dohme (Consultant)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    99. Immune Responses to Influenza Vaccines in Children and Young Adults
Herramientas de búsqueda: RSS